Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
577.30
-8.91 (-1.52%)
Dec 5, 2025, 4:00 PM EST - Market closed
Madrigal Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 13,111 | 6,730 | 4,568 | 5,179 | 1,449 | 1,719 | |
| Market Cap Growth | 91.34% | 47.33% | -11.79% | 257.45% | -15.74% | 22.31% | |
| Enterprise Value | 12,348 | 5,851 | 4,452 | 5,075 | 1,151 | 1,384 | |
| Last Close Price | 577.30 | 308.57 | 231.38 | 290.25 | 84.74 | 111.17 | |
| PS Ratio | 17.29 | 37.36 | - | - | - | - | |
| PB Ratio | 20.95 | 8.92 | 11.27 | 26.24 | 7.39 | 7.17 | |
| P/TBV Ratio | 21.21 | 8.98 | 11.27 | 26.24 | 7.39 | 7.17 | |
| EV/Sales Ratio | 16.67 | 32.48 | - | - | - | - | |
| Debt / Equity Ratio | 0.55 | 0.16 | 0.29 | 0.25 | 0.00 | 0.00 | |
| Asset Turnover | 0.61 | 0.21 | - | - | - | - | |
| Quick Ratio | 3.13 | 5.79 | 5.35 | 3.10 | 3.52 | 6.10 | |
| Current Ratio | 3.44 | 6.10 | 5.38 | 3.12 | 3.54 | 6.13 | |
| Return on Equity (ROE) | -41.22% | -80.35% | -123.98% | -150.12% | -110.92% | -61.61% | |
| Return on Assets (ROA) | -15.78% | -36.98% | -47.41% | -57.71% | -54.09% | -35.44% | |
| Return on Capital (ROIC) | -20.57% | -44.56% | -61.78% | -82.62% | -69.25% | -39.26% | |
| Return on Capital Employed (ROCE) | -31.70% | -57.00% | -72.90% | -119.00% | -123.40% | -86.00% | |
| Earnings Yield | -2.21% | -6.92% | -8.18% | -5.70% | -16.69% | -11.76% | |
| FCF Yield | -1.23% | -6.79% | -7.13% | -4.35% | -12.71% | -9.18% | |
| Buyback Yield / Dilution | -6.98% | -13.83% | -9.05% | -3.64% | -7.05% | -0.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.